_id

690dadc6ccc777a4e85d0a39

Ticker

ALVOW

Name

Alvotech Warrant

Exchange

NASDAQ

Address

9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273

Country

USA

Sector

Industry

Currency

USD

Website

https://www.alvotech.com

Description

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Last Close

0.62

Volume

5579

Current Price

0.51

Change

-0.13

Last Updated

2026-01-14T11:58:21.011Z

Image

data:image/webp;base64,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

Ipo Date

2022-06-16T00:00:00.000Z

Market Cap

-

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

-

Target Price

-

Strong Buy

-

Buy

-

Hold

-

Sell

-

Strong Sell

-

Current Quarter

2025-09-30

Revenue

113953000

Cost Of Revenue

35028000

Gross Profit

78925000

Operating Expenses

77564000

Operating Income

1361000

Interest Expense

36259000

Pretax Income

-6031000

Net Income

-5218000

Eps

-0.017379759219989743

Dividends Per Share

-

Shares Outstanding

0

Income Tax Expense

-813000

EBITDA

3685000

Operating Margin

1.1943520574271849

Total Other Income Expense Net

-7392000

Cash

42848000

Short Term Investments

-

Receivables

121351000

Inventories

207729000

Total Current Assets

432006000

Property Plant Equipment

494180000

Total Assets

1409178000

Payables

91628000

Short Term Debt

56019000

Long Term Debt

1081626000

Total Liabilities

1585941000

Equity

-176763000

Bs_currency_symbol

USD

Depreciation

10282000

Change In Working Capital

-59132000

Cash From Operations

-55575000

Capital Expenditures

18926000

Cash From Investing

-39451000

Cash From Financing

-13245000

Net Change In Cash

-108604000

Cf_currency_symbol

USD

PE

-

PB

-0.8662417903633679

ROE

2.9519752436878757

ROA

-0.370286791306705

FCF

-74501000

Fcf Percent

-0.6537870876589471

Piotroski FScore

0

Health Score

17

Deep Value Investing Score

0.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.8

Garp Investing Score

1

Growth Investing Score

1.5

Momentum Investing Score

6.5

Net Net Investing Score

0

Quality Investing Score

1

Value Investing Score

1

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

113953000

Quarters > 0 > income Statement > cost Of Revenue

35028000

Quarters > 0 > income Statement > gross Profit

78925000

Quarters > 0 > income Statement > operating Expenses

77564000

Quarters > 0 > income Statement > operating Income

1361000

Quarters > 0 > income Statement > interest Expense

36259000

Quarters > 0 > income Statement > pretax Income

-6031000

Quarters > 0 > income Statement > net Income

-5218000

Quarters > 0 > income Statement > eps

-0.017379759219989743

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

300234309

Quarters > 0 > income Statement > income Tax Expense

-813000

Quarters > 0 > income Statement > EBITDA

3685000

Quarters > 0 > income Statement > operating Margin

1.1943520574271849

Quarters > 0 > income Statement > total Other Income Expense Net

-7392000

Quarters > 0 > income Statement > currency_symbol

USD

Quarters > 0 > balance Sheet > cash

42848000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

121351000

Quarters > 0 > balance Sheet > inventories

207729000

Quarters > 0 > balance Sheet > total Current Assets

432006000

Quarters > 0 > balance Sheet > property Plant Equipment

494180000

Quarters > 0 > balance Sheet > total Assets

1409178000

Quarters > 0 > balance Sheet > payables

91628000

Quarters > 0 > balance Sheet > short Term Debt

56019000

Quarters > 0 > balance Sheet > long Term Debt

1081626000

Quarters > 0 > balance Sheet > total Liabilities

1585941000

Quarters > 0 > balance Sheet > equity

-176763000

Quarters > 0 > balance Sheet > currency_symbol

USD

Quarters > 0 > cash Flow > net Income

-5252000

Quarters > 0 > cash Flow > depreciation

10282000

Quarters > 0 > cash Flow > change In Working Capital

-59132000

Quarters > 0 > cash Flow > cash From Operations

-55575000

Quarters > 0 > cash Flow > capital Expenditures

18926000

Quarters > 0 > cash Flow > cash From Investing

-39451000

Quarters > 0 > cash Flow > cash From Financing

-13245000

Quarters > 0 > cash Flow > net Change In Cash

-108604000

Quarters > 0 > cash Flow > currency_symbol

USD

Quarters > 0 > ratios > PE

-0.017379759219989743

Quarters > 0 > ratios > PB

-0.8662417903633679

Quarters > 0 > ratios > ROE

2.9519752436878757

Quarters > 0 > ratios > ROA

-0.370286791306705

Quarters > 0 > ratios > FCF

-74501000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-0.6537870876589471

Quarters > 0 > health Score

17

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

173239000

Quarters > 1 > income Statement > cost Of Revenue

73825000

Quarters > 1 > income Statement > gross Profit

99414000

Quarters > 1 > income Statement > operating Expenses

81357000

Quarters > 1 > income Statement > operating Income

18057000

Quarters > 1 > income Statement > interest Expense

36651000

Quarters > 1 > income Statement > pretax Income

9310000

Quarters > 1 > income Statement > net Income

32038000

Quarters > 1 > income Statement > eps

0.10223650606003395

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

313371429

Quarters > 1 > income Statement > income Tax Expense

-22728000

Quarters > 1 > income Statement > EBITDA

51742000

Quarters > 1 > income Statement > operating Margin

10.423172611248045

Quarters > 1 > income Statement > total Other Income Expense Net

-8747000

Quarters > 1 > income Statement > currency_symbol

USD

Quarters > 1 > balance Sheet > cash

151452000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

180411000

Quarters > 1 > balance Sheet > inventories

155490000

Quarters > 1 > balance Sheet > total Current Assets

509461000

Quarters > 1 > balance Sheet > property Plant Equipment

441077000

Quarters > 1 > balance Sheet > total Assets

1392754000

Quarters > 1 > balance Sheet > payables

84282000

Quarters > 1 > balance Sheet > short Term Debt

59617000

Quarters > 1 > balance Sheet > long Term Debt

1072138000

Quarters > 1 > balance Sheet > total Liabilities

1566082000

Quarters > 1 > balance Sheet > equity

-173328000

Quarters > 1 > balance Sheet > currency_symbol

USD

Quarters > 1 > cash Flow > net Income

32037999

Quarters > 1 > cash Flow > depreciation

8897000

Quarters > 1 > cash Flow > change In Working Capital

24825000

Quarters > 1 > cash Flow > cash From Operations

55742000

Quarters > 1 > cash Flow > capital Expenditures

13618000

Quarters > 1 > cash Flow > cash From Investing

-28603000

Quarters > 1 > cash Flow > cash From Financing

83147000

Quarters > 1 > cash Flow > net Change In Cash

112908000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

0.10223650606003395

Quarters > 1 > ratios > PB

-0.9220635372819163

Quarters > 1 > ratios > ROE

-18.484030277854703

Quarters > 1 > ratios > ROA

2.300334445278922

Quarters > 1 > ratios > FCF

42124000

Quarters > 1 > ratios > Piotroski FScore

3

Quarters > 1 > ratios > fcf Percent

0.24315540957867454

Quarters > 1 > health Score

52

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

132765000

Quarters > 2 > income Statement > cost Of Revenue

65447000

Quarters > 2 > income Statement > gross Profit

67318000

Quarters > 2 > income Statement > operating Expenses

56736000

Quarters > 2 > income Statement > operating Income

10582000

Quarters > 2 > income Statement > interest Expense

35539000

Quarters > 2 > income Statement > pretax Income

93421000

Quarters > 2 > income Statement > net Income

109680000

Quarters > 2 > income Statement > eps

0.3499999995213348

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

313371429

Quarters > 2 > income Statement > income Tax Expense

-16259000

Quarters > 2 > income Statement > EBITDA

137219000

Quarters > 2 > income Statement > operating Margin

7.970474146047528

Quarters > 2 > income Statement > total Other Income Expense Net

82839000

Quarters > 2 > income Statement > currency_symbol

USD

Quarters > 2 > balance Sheet > cash

38544000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

228751000

Quarters > 2 > balance Sheet > inventories

142074000

Quarters > 2 > balance Sheet > total Current Assets

458872000

Quarters > 2 > balance Sheet > property Plant Equipment

422912000

Quarters > 2 > balance Sheet > total Assets

1245462000

Quarters > 2 > balance Sheet > payables

67887000

Quarters > 2 > balance Sheet > short Term Debt

43820000

Quarters > 2 > balance Sheet > long Term Debt

1063972000

Quarters > 2 > balance Sheet > total Liabilities

1547749000

Quarters > 2 > balance Sheet > equity

-302287000

Quarters > 2 > balance Sheet > currency_symbol

USD

Quarters > 2 > cash Flow > net Income

109680000

Quarters > 2 > cash Flow > depreciation

8259000

Quarters > 2 > cash Flow > change In Working Capital

-3450000

Quarters > 2 > cash Flow > cash From Operations

12549000

Quarters > 2 > cash Flow > capital Expenditures

23370000

Quarters > 2 > cash Flow > cash From Investing

-20395000

Quarters > 2 > cash Flow > cash From Financing

-5839000

Quarters > 2 > cash Flow > net Change In Cash

-12884000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

0.3499999995213348

Quarters > 2 > ratios > PB

-0.5287009656055338

Quarters > 2 > ratios > ROE

-36.283399550758055

Quarters > 2 > ratios > ROA

8.8063706480005

Quarters > 2 > ratios > FCF

-10821000

Quarters > 2 > ratios > Piotroski FScore

2

Quarters > 2 > ratios > fcf Percent

-0.08150491469890409

Quarters > 2 > health Score

39

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

151205000

Quarters > 3 > income Statement > cost Of Revenue

80330000

Quarters > 3 > income Statement > gross Profit

70875000

Quarters > 3 > income Statement > operating Expenses

57404000

Quarters > 3 > income Statement > operating Income

13471000

Quarters > 3 > income Statement > interest Expense

159198000

Quarters > 3 > income Statement > pretax Income

-44441000

Quarters > 3 > income Statement > net Income

-66967000

Quarters > 3 > income Statement > eps

-0.2218878076306033

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

301805677

Quarters > 3 > income Statement > income Tax Expense

22526000

Quarters > 3 > income Statement > EBITDA

-119982000

Quarters > 3 > income Statement > operating Margin

8.909096921398103

Quarters > 3 > income Statement > total Other Income Expense Net

-57912000

Quarters > 3 > income Statement > currency_symbol

USD

Quarters > 3 > balance Sheet > cash

51428000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

251719000

Quarters > 3 > balance Sheet > inventories

127889000

Quarters > 3 > balance Sheet > total Current Assets

455020000

Quarters > 3 > balance Sheet > property Plant Equipment

409744000

Quarters > 3 > balance Sheet > total Assets

1221400000

Quarters > 3 > balance Sheet > payables

67126000

Quarters > 3 > balance Sheet > short Term Debt

42217000

Quarters > 3 > balance Sheet > long Term Debt

1035882000

Quarters > 3 > balance Sheet > total Liabilities

1634171000

Quarters > 3 > balance Sheet > equity

-412771000

Quarters > 3 > balance Sheet > currency_symbol

USD

Quarters > 3 > cash Flow > net Income

-66967000

Quarters > 3 > cash Flow > depreciation

8155000

Quarters > 3 > cash Flow > change In Working Capital

-59207000

Quarters > 3 > cash Flow > cash From Operations

-39202000

Quarters > 3 > cash Flow > capital Expenditures

31052000

Quarters > 3 > cash Flow > cash From Investing

-31052000

Quarters > 3 > cash Flow > cash From Financing

4296000

Quarters > 3 > cash Flow > net Change In Cash

-66846000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.2218878076306033

Quarters > 3 > ratios > PB

-0.3728965825360793

Quarters > 3 > ratios > ROE

16.223765719975482

Quarters > 3 > ratios > ROA

-5.482806615359424

Quarters > 3 > ratios > FCF

-70254000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.4646274924771006

Quarters > 3 > health Score

28

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

489682000

Annuals > 0 > income Statement > cost Of Revenue

185309000

Annuals > 0 > income Statement > gross Profit

304373000

Annuals > 0 > income Statement > operating Expenses

234729000

Annuals > 0 > income Statement > operating Income

69644000

Annuals > 0 > income Statement > interest Expense

157601000

Annuals > 0 > income Statement > pretax Income

-217563000

Annuals > 0 > income Statement > net Income

-231864000

Annuals > 0 > income Statement > eps

-0.8654077526372441

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

267924570

Annuals > 0 > income Statement > income Tax Expense

14301000

Annuals > 0 > income Statement > EBITDA

-32275000

Annuals > 0 > income Statement > operating Margin

14.22229120122855

Annuals > 0 > income Statement > total Other Income Expense Net

-287207000

Annuals > 0 > income Statement > currency_symbol

USD

Annuals > 0 > balance Sheet > cash

51428000

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

251719000

Annuals > 0 > balance Sheet > inventories

127889000

Annuals > 0 > balance Sheet > total Current Assets

455020000

Annuals > 0 > balance Sheet > property Plant Equipment

409744000

Annuals > 0 > balance Sheet > total Assets

1221400000

Annuals > 0 > balance Sheet > payables

67126000

Annuals > 0 > balance Sheet > short Term Debt

42217000

Annuals > 0 > balance Sheet > long Term Debt

1035882000

Annuals > 0 > balance Sheet > total Liabilities

1634171000

Annuals > 0 > balance Sheet > equity

-412771000

Annuals > 0 > balance Sheet > currency_symbol

USD

Annuals > 0 > cash Flow > net Income

-231864000

Annuals > 0 > cash Flow > depreciation

31301000

Annuals > 0 > cash Flow > change In Working Capital

-288644000

Annuals > 0 > cash Flow > cash From Operations

-236843000

Annuals > 0 > cash Flow > capital Expenditures

57000000

Annuals > 0 > cash Flow > cash From Investing

-18868000

Annuals > 0 > cash Flow > cash From Financing

297306000

Annuals > 0 > cash Flow > net Change In Cash

40271000

Annuals > 0 > cash Flow > currency_symbol

USD

Annuals > 0 > ratios > PE

-0.8654077526372441

Annuals > 0 > ratios > PB

-0.33103471585939903

Annuals > 0 > ratios > ROE

56.17255088172376

Annuals > 0 > ratios > ROA

-18.983461601440972

Annuals > 0 > ratios > FCF

-293843000

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-0.6000690243872554

Annuals > 0 > health Score

31

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

91434000

Annuals > 1 > income Statement > cost Of Revenue

160856000

Annuals > 1 > income Statement > gross Profit

-69422000

Annuals > 1 > income Statement > operating Expenses

285438000

Annuals > 1 > income Statement > operating Income

-354860000

Annuals > 1 > income Statement > interest Expense

134824000

Annuals > 1 > income Statement > pretax Income

-651049000

Annuals > 1 > income Statement > net Income

-551731000

Annuals > 1 > income Statement > eps

-2.4277900753619472

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

227256469

Annuals > 1 > income Statement > income Tax Expense

-99318000

Annuals > 1 > income Statement > EBITDA

-493672000

Annuals > 1 > income Statement > operating Margin

-388.10508126080015

Annuals > 1 > income Statement > total Other Income Expense Net

-296189000

Annuals > 1 > income Statement > currency_symbol

USD

Annuals > 1 > balance Sheet > cash

11157000

Annuals > 1 > balance Sheet > short Term Investments

-

Annuals > 1 > balance Sheet > receivables

87217000

Annuals > 1 > balance Sheet > inventories

74433000

Annuals > 1 > balance Sheet > total Current Assets

194842000

Annuals > 1 > balance Sheet > property Plant Equipment

356581000

Annuals > 1 > balance Sheet > total Assets

950090000

Annuals > 1 > balance Sheet > payables

80563000

Annuals > 1 > balance Sheet > short Term Debt

47708000

Annuals > 1 > balance Sheet > long Term Debt

922134000

Annuals > 1 > balance Sheet > total Liabilities

1882583000

Annuals > 1 > balance Sheet > equity

-932493000

Annuals > 1 > balance Sheet > currency_symbol

USD

Annuals > 1 > cash Flow > net Income

-551731000

Annuals > 1 > cash Flow > depreciation

24210000

Annuals > 1 > cash Flow > change In Working Capital

26328000

Annuals > 1 > cash Flow > cash From Operations

-312185000

Annuals > 1 > cash Flow > capital Expenditures

46473000

Annuals > 1 > cash Flow > cash From Investing

-46340000

Annuals > 1 > cash Flow > cash From Financing

301319000

Annuals > 1 > cash Flow > net Change In Cash

-55270000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-2.4277900753619472

Annuals > 1 > ratios > PB

-0.12429133429419847

Annuals > 1 > ratios > ROE

59.16730742214686

Annuals > 1 > ratios > ROA

-58.071445863023506

Annuals > 1 > ratios > FCF

-358658000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-3.92258897127983

Annuals > 1 > health Score

30

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

83029000

Annuals > 2 > income Statement > cost Of Revenue

64095000

Annuals > 2 > income Statement > gross Profit

18934000

Annuals > 2 > income Statement > operating Expenses

365376000

Annuals > 2 > income Statement > operating Income

-346442000

Annuals > 2 > income Statement > interest Expense

91438000

Annuals > 2 > income Statement > pretax Income

-551647000

Annuals > 2 > income Statement > net Income

-513580000

Annuals > 2 > income Statement > eps

-2.5974891679826158

Annuals > 2 > income Statement > dividends Per Share

184757000

Annuals > 2 > income Statement > shares Outstanding

197721710

Annuals > 2 > income Statement > income Tax Expense

-38067000

Annuals > 2 > income Statement > EBITDA

-439800000

Annuals > 2 > income Statement > operating Margin

-417.254212383625

Annuals > 2 > income Statement > total Other Income Expense Net

-205205000

Annuals > 2 > income Statement > currency_symbol

USD

Annuals > 2 > balance Sheet > cash

66427000

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

71387000

Annuals > 2 > balance Sheet > inventories

71470000

Annuals > 2 > balance Sheet > total Current Assets

230736000

Annuals > 2 > balance Sheet > property Plant Equipment

268095000

Annuals > 2 > balance Sheet > total Assets

828443000

Annuals > 2 > balance Sheet > payables

49188000

Annuals > 2 > balance Sheet > short Term Debt

25079000

Annuals > 2 > balance Sheet > long Term Debt

744654000

Annuals > 2 > balance Sheet > total Liabilities

1392859000

Annuals > 2 > balance Sheet > equity

-564416000

Annuals > 2 > balance Sheet > currency_symbol

USD

Annuals > 2 > cash Flow > net Income

-513580000

Annuals > 2 > cash Flow > depreciation

20409000

Annuals > 2 > cash Flow > change In Working Capital

-47890000

Annuals > 2 > cash Flow > cash From Operations

-312389000

Annuals > 2 > cash Flow > capital Expenditures

49002000

Annuals > 2 > cash Flow > cash From Investing

-63537000

Annuals > 2 > cash Flow > cash From Financing

424910000

Annuals > 2 > cash Flow > net Change In Cash

48871000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-2.5974891679826158

Annuals > 2 > ratios > PB

-0.17865913103101258

Annuals > 2 > ratios > ROE

90.9931681596553

Annuals > 2 > ratios > ROA

-61.9934020807708

Annuals > 2 > ratios > FCF

-361391000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-4.352587650098158

Annuals > 2 > health Score

30

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

36772000

Annuals > 3 > income Statement > cost Of Revenue

0

Annuals > 3 > income Statement > gross Profit

36772000

Annuals > 3 > income Statement > operating Expenses

272228000

Annuals > 3 > income Statement > operating Income

-235456000

Annuals > 3 > income Statement > interest Expense

112971000

Annuals > 3 > income Statement > pretax Income

-149198000

Annuals > 3 > income Statement > net Income

-101504000

Annuals > 3 > income Statement > eps

-3.248128

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

31250000

Annuals > 3 > income Statement > income Tax Expense

-47694000

Annuals > 3 > income Statement > EBITDA

-18031000

Annuals > 3 > income Statement > operating Margin

-640.313281844882

Annuals > 3 > income Statement > total Other Income Expense Net

86258000

Annuals > 3 > income Statement > currency_symbol

USD

Annuals > 3 > balance Sheet > cash

17556000

Annuals > 3 > balance Sheet > short Term Investments

-

Annuals > 3 > balance Sheet > receivables

53882000

Annuals > 3 > balance Sheet > inventories

39058000

Annuals > 3 > balance Sheet > total Current Assets

119816000

Annuals > 3 > balance Sheet > property Plant Equipment

205331000

Annuals > 3 > balance Sheet > total Assets

597977000

Annuals > 3 > balance Sheet > payables

28587000

Annuals > 3 > balance Sheet > short Term Debt

10066000

Annuals > 3 > balance Sheet > long Term Debt

398140000

Annuals > 3 > balance Sheet > total Liabilities

733589000

Annuals > 3 > balance Sheet > equity

-135612000

Annuals > 3 > balance Sheet > currency_symbol

USD

Annuals > 3 > cash Flow > net Income

-101504000

Annuals > 3 > cash Flow > depreciation

18196000

Annuals > 3 > cash Flow > change In Working Capital

-6807000

Annuals > 3 > cash Flow > cash From Operations

-228170000

Annuals > 3 > cash Flow > capital Expenditures

40633000

Annuals > 3 > cash Flow > cash From Investing

-40633000

Annuals > 3 > cash Flow > cash From Financing

254831000

Annuals > 3 > cash Flow > net Change In Cash

-14133000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-3.248128

Annuals > 3 > ratios > PB

-0.1175227855941952

Annuals > 3 > ratios > ROE

74.84883343656904

Annuals > 3 > ratios > ROA

-16.974565911397928

Annuals > 3 > ratios > FCF

-268803000

Annuals > 3 > ratios > Piotroski FScore

1

Annuals > 3 > ratios > fcf Percent

-7.309991297726531

Annuals > 3 > health Score

31

Valuation > metrics > PE

-0.017379759219989743

Valuation > metrics > PB

-0.8662417903633679

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

2.9519752436878757

Profitability > metrics > ROA

-1.2078535946260005

Profitability > metrics > Net Margin

-0.04579080849122007

Profitability > final Score

6

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

0.03753550842549436

Risk > final Score

30

Risk > verdict

High

Liquidity > metrics > Current Ratio

2.9259382175052657

Liquidity > metrics > Quick Ratio

1.5190081749036553

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

50

Prev Profitabilities > 0

47

Prev Profitabilities > 1

60

Prev Profitabilities > 2

32

Prev Risks > 0

32

Prev Risks > 1

31

Prev Risks > 2

30

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T21:22:43.520Z